螺旋调强放疗联合同期化疗治疗口咽鳞癌:急性吞咽与毒性模式的前瞻性研究
该前瞻性研究纳入76例接受螺旋调强放疗联合同期化疗的口咽鳞癌患者,每周及治疗后2、4、12周评估吞咽困难与急性毒性。结果显示3级吞咽困难发生率达61%,症状在第7周达峰后改善,T3-T4肿瘤的3级吞咽困难发生率是T2的两倍。
要点
- 螺旋调强放疗联合同期化疗期间3级吞咽困难发生率为61%
- 急性毒性症状在第7周达峰,此后逐渐改善
- T3-T4肿瘤患者3级吞咽困难风险为T2的两倍
核心结论
- 口咽鳞癌患者接受螺旋调强放疗联合同期化疗仍会出现与其他适形技术相当的急性毒性反应,需要支持治疗。
研究设计与样本
- 前瞻性研究,纳入76例接受螺旋调强放疗联合同期化疗的口咽鳞癌患者。
- 治疗期间每周及治疗后2、4、12周采用功能经口摄入量表、饮食描述和CTCAE 4.0版收集吞咽困难与急性毒性数据。
主要发现
- 3级吞咽困难发生率为61%,3级黏膜炎为30%,3级浓稠唾液为38%。
- 2级口干发生率为87%,2级味觉障碍为97%。
- 仅14.5%的患者完全不能经口进食。
- 症状在第7周达峰,此后改善。
- T3-T4肿瘤的3级吞咽困难发生率是T2的两倍。
临床怎么用
- 应预期螺旋调强放疗联合同期化疗期间出现较高的急性吞咽困难和黏膜炎发生率,并加强支持治疗。
- T3-T4肿瘤患者需特别关注3级吞咽困难风险,加强吞咽功能监测与干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conformal radiotherapy modalities may minimize treatment toxicities. The purpose of this study was to document the extent and timing of dysphagia and related toxicities during helical intensity-modulated radiotherapy (IMRT) with chemotherapy for oropharyngeal squamous cell carcinoma (SCC). METHODS: We conducted a prospective study of 76 patients with oropharyngeal SCC undergoing helical IMRT with chemotherapy. Dysphagia and acute toxicity data were collected weekly during treatment and at 2, 4, and 12 weeks posttreatment using the Functional Oral Intake Scale, diet descriptors, and Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. RESULTS: Patients experienced maximum incidence of grade 3 dysphagia (61%), mucositis (30%), and thick saliva (38%), with grade 2 xerostomia (87%) and dysgeusia (97%). Only 14.5% were nil-by-mouth. Symptoms peaked in week 7 and improved thereafter. Grade 3 dysphagia was twice as common for T3 to T4 tumors compared with T2. CONCLUSION: Results confirm that patients with oropharyngeal SCC undergoing helical IMRT with chemotherapy continue to experience incidences of acute toxicities comparable with other conformal techniques, and need supportive cares.
引用
- Moroney LB, Helios J, Ward EC, et al. Helical intensity-modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns. Head Neck. 2018. PMID: 29756244. doi:10.1002/hed.25182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。